Search Orphan Drug Designations and Approvals
-
Generic Name: | peptide 144 TGF beta-1 inhibitor |
---|---|
Date Designated: | 04/27/2006 |
Orphan Designation: | Treatment of systemic sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Digna Biotech, S.L. Calloe ORENSE No. 85 2nd Floor Madrid Spain The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-